---
date: '2000-09-21'
id: 116EE
page: 13
number: 184
agency: SERVICIO GALEGO DE SAÚDE
section: VI. ANUNCIOS
title: >-
  Resolución do 16 de agosto de 2000, da Xerencia do Complexo Hospitalario
  Arquitecto Marcide-Profesor Novoa Santos de Ferrol, pola que se fai pública a
  adxudicación definitiva dos expedientes CP 1/2000 e sete máis.
range: Resolución
url: 'https://www.xunta.gal/dog/Publicados/2000/20000921/Anuncio116EE_gl.html'
---
<p>A Dirección Xerencia do Complexo Hospitalario Arquitecto Marcide-Profesor Novoa Santos, en virtude das atribucións que lle foron delegadas conforme o establecido no artigo 7 da orde da Consellería de Sanidade e Servicios Sociais, do 21 de abril de 1998 (DOG nº 88, do 11 de maio), sobre delegación de competencias en órganos centrais e periféricos</p>
<p>do Sergas, e para cumprimento do previsto no artigo 94 da Lei 13/1995 do 18 de maio, de contratos coas administracións públicas, acorda darlle publicidade á adxudicación dos seguintes contratos:</p>
<p>1. Entidade adxudicataria.</p>
<p>a) Organismo: Servicio Galego de Saúde. Complexo Hospitalario Arquitecto Marcide-Profesor Novoa Santos, estrada de San Pedro, s/n, 15405-Ferrol.</p>
<p>b) Dependencia que tramita o expediente: Servicio de Subministracións, Unidade de Contratación. Teléfono 981 33 45 14. Fax 981 33 40 84.</p>
<p>2. Obxecto da contratación.</p>
<p>a) Tipo de contrato:</p>
<p>-CP 1, 12, 14, 15, 16, 18 y 19/2000: subministracións.</p>
<p>-CP 21/2000: subministracións sucesivas.</p>
<p>b) Descrición do obxecto.</p>
<p>CP 1/2000: lentes intraoculares e material de oftalmoloxía.</p>
<p>CP 12/2000: material de recollida de mostras.</p>
<p>CP 14/2000: material de hixiene e protección.</p>
<p>CP 15/2000: catéteres e material de punción e incisión.</p>
<p>CP 16/2000: cánulas, sondas e tubos.</p>
<p>CP 18/2000: suturas mecánicas e fíos de sutura.</p>
<p>CP 19/2000: material de unidade da dor.</p>
<p>CP 21/2000: subministracións sucesivas de implantes destinados á unidade da dor.</p>
<p>c) Lotes: véxase punto 5.</p>
<p>d) Data de publicación do anuncio de licitación.</p>
<p>CP 1/2000: DOG nº 49, do 10 de marzo de 2000.</p>
<p>CP 12 y 14/2000: DOG nº 70, do 10 de abril de 2000.</p>
<p>CP 15, 16, 18 y 19/2000: DOG nº 77, do 19 de abril de 2000.</p>
<p>CP 21/2000: DOG nº 81, do 27 de abril de 2000.</p>
<p>3. Tramitación, procedemento e forma de adxudicación.</p>
<p>Tramitación:</p>
<p>CP 1, 12, 14, 15, 16, 18, 19 e 21/2000: ordinaria.</p>
<p>b) Procedemento: aberto.</p>
<p>c) Forma: concurso.</p>
<p>4. Orzamento base de licitación.</p>
<p>CP 1/2000: 7.156.158 ptas. (43.009,38 euros) (IVE incluído).</p>
<p>CP 12/2000: 32.111.143 ptas. (192.991,86 euros) (IVE incluído).</p>
<p>CP 14/2000: 22.242.042 ptas. (133.677,36 euros) (IVE incluído).</p>
<p>CP 15/2000: 25.329.041 ptas. (152.230,60 euros) (IVE incluído).</p>
<p>CP 16/2000: 14.181.782 ptas. (85.234,23 euros) (IVE incluído).</p>
<p>CP 18/2000: 11.732.048 ptas. (70.511,03 euros) (IVE incluído).</p>
<p>CP 19/2000: 14.465.128 ptas. (86.937,17 euros) (IVE incluído).</p>
<p>CP 21/2000: 16.661.539 ptas. (100.137,87 euros) (IVE incluído).</p>
<p>5. Adxudicación.</p>
<p>a) Data:</p>
<p>CP 1, 12, 14, 15, 18, 19 e 21/2000: 28 de xullo de 2000.</p>
<p>CP 16/2000: 8 de agosto de 2000.</p>
<p>b) Contratistas:</p>
<p>* CP 1/2000:</p>
<table><tbody><tr><td></td></tr>
<tr><td></td></tr>
<tr><td>ADXUDICATARIO</td><td>LOTE</td><td>IMPORTE TOTAL</td><td>TOTAL (EUROS)</td></tr>
<tr><td></td></tr>
</tbody></table>
<table><tbody><tr><td>ALLERGAN, S.A.</td><td>1</td><td>1.070.000</td><td>6.430,83</td></tr>
<tr><td></td></tr>
<tr><td>ALCON CUSI, S.A.</td><td>2</td><td>2.728.500</td><td>16.398,62</td></tr>
<tr><td></td></tr>
<tr><td>B. BRAUN DEXON, S.A.</td><td>3</td><td>333.300</td><td>2.003,17</td></tr>
<tr><td></td></tr>
<tr><td>B. BRAUN DEXON, S.A.</td><td>4</td><td>468.000</td><td>2.812,74</td></tr>
<tr><td></td></tr>
<tr><td>CORNEAL ESPAÑA, S.L.</td><td>5</td><td>652.550</td><td>3.921,90</td></tr>
<tr><td></td></tr>
<tr><td>JOHNSON &amp; JOHNSON, S.A.</td><td>6</td><td>978.575</td><td>5.881,35</td></tr>
<tr><td></td></tr>
<tr><td>B. BRAUN DEXON, S.A.</td><td>7</td><td>144.000</td><td>865,46</td></tr>
<tr><td></td></tr>
<tr><td>BIOGAL, S.A.</td><td>8</td><td>111.600</td><td>670,73</td></tr>
<tr><td></td></tr>
<tr><td>JOHNSON &amp; JOHNSON, S.A.</td><td>9</td><td>222.453</td><td>1.336,97</td></tr>
<tr><td></td></tr>
<tr><td>IMPORTE TOTAL</td><td></td><td>6.708.978</td><td>40.321,77</td></tr>
<tr><td></td></tr></tbody></table>
<p>* CP 12/2000:</p>
<table><tbody><tr><td></td></tr>
<tr><td></td></tr>
<tr><td>ADXUDICATARIO</td><td>LOTE</td><td>IMPORTE TOTAL</td><td>TOTAL (EUROS)</td></tr>
<tr><td></td></tr>
</tbody></table>
<table><tbody><tr><td>KERBAK, S.L.</td><td>1</td><td>16.626.800</td><td>99.929,08</td></tr>
<tr><td></td></tr>
<tr><td>ABBOTT LABORATORIES, S.A.</td><td>2</td><td>1.947.400</td><td>11.704,11</td></tr>
<tr><td></td></tr>
<tr><td>KERBAK, S.L.</td><td>3</td><td>2.300.500</td><td>13.826,28</td></tr>
<tr><td></td></tr>
<tr><td>HOLLISTER IBERICA, S.A.</td><td>4</td><td>929.760</td><td>5.587,97</td></tr>
<tr><td></td></tr>
<tr><td>COLOPLAST PRODUCT. MEDIC., S.A.</td><td>5</td><td>369.632</td><td>2.221,53</td></tr>
<tr><td></td></tr>
<tr><td>IBERHOSPITEX, S.A.</td><td>6</td><td>1.210.800</td><td>7.277,05</td></tr>
<tr><td></td></tr>
<tr><td>B. BRAUN MEDICAL, S.A.</td><td>7</td><td>712.331</td><td>4.281,20</td></tr>
<tr><td></td></tr>
<tr><td>HORTAS SUMINISTROS, S.L.</td><td>9</td><td>519.924</td><td>3.124,81</td></tr>
<tr><td></td></tr>
<tr><td>SANICEN, S.A.</td><td>10</td><td>817.344</td><td>4.912,34</td></tr>
<tr><td></td></tr>
<tr><td>FRANCISCO SORIA MELGUIZO, S.A.</td><td>11</td><td>850.560</td><td>5.111,97</td></tr>
<tr><td></td></tr>
<tr><td>SANICEN, S.A.</td><td>12</td><td>192.000</td><td>1.153,94</td></tr>
<tr><td></td></tr>
<tr><td>CLÍNICA Y CONTROL, S.A.</td><td>13</td><td>1.146.600</td><td>6.891,20</td></tr>
<tr><td></td></tr>
<tr><td>SUMCYL, S.L.</td><td>14</td><td>339.100</td><td>2.038,03</td></tr>
<tr><td></td></tr>
<tr><td>KRAPE, S.A.</td><td>15</td><td>160.500</td><td>964,62</td></tr>
<tr><td></td></tr>
<tr><td>KRAPE, S.A.</td><td>16</td><td>66.780</td><td>401,36</td></tr>
<tr><td></td></tr>
<tr><td>PRODUCTOS PALEX, S.A.</td><td>18</td><td>455.000</td><td>2.734,61</td></tr>
<tr><td></td></tr>
<tr><td>RAMÓN CRUZ DISTRIBUCIONES, S.L.</td><td>19</td><td>898.800</td><td>5.401,90</td></tr>
<tr><td></td></tr>
<tr><td>IMPORTES TOTAIS</td><td></td><td>29.543.831</td><td>177.562,00</td></tr>
<tr><td></td></tr></tbody></table>
<p>* CP 14/2000:</p>
<table><tbody><tr><td></td></tr>
<tr><td></td></tr>
<tr><td>ADXUDICATARIO</td><td>LOTE</td><td>IMPORTE TOTAL</td><td>TOTAL (EUROS)</td></tr>
<tr><td></td></tr>
</tbody></table>
<table><tbody><tr><td>JOHNSON &amp; JOHNSON, S.A.</td><td>1</td><td>453.680</td><td>2.726,67</td></tr>
<tr><td></td></tr>
<tr><td>MOLNLYCKE HEALTH CARE, S.L.</td><td>2</td><td>769.544</td><td>4.625,05</td></tr>
<tr><td></td></tr>
<tr><td>COMERCIAL DISPOTEX, S.A.</td><td>3</td><td>215.600</td><td>1.295,78</td></tr>
<tr><td></td></tr>
<tr><td>BAXTER, S.L.</td><td>4</td><td>80.000</td><td>480,81</td></tr>
<tr><td></td></tr>
<tr><td>HORTAS SUMINISTROS, S.L.</td><td>5</td><td>183.505</td><td>1.102,89</td></tr>
<tr><td></td></tr>
<tr><td>LABORATORIOS INDAS, S.A.</td><td>7</td><td>4.512.912</td><td>27.123,15</td></tr>
<tr><td></td></tr>
<tr><td>MOLNLYCKE HEALTH CARE, S.L.</td><td>8</td><td>484.735</td><td>2.913,32</td></tr>
<tr><td></td></tr>
<tr><td>HORTAS SUMINISTROS, S.L.</td><td>9</td><td>175.266</td><td>1.053,37</td></tr>
<tr><td></td></tr>
<tr><td>KRAPE, S.A.</td><td>10</td><td>261.375</td><td>1.570,90</td></tr>
<tr><td></td></tr>
<tr><td>KRAPE, S.A.</td><td>11</td><td>754.350</td><td>4.533,73</td></tr>
<tr><td></td></tr></tbody></table>
<table><tbody><tr><td></td></tr>
<tr><td></td></tr>
<tr><td>ADXUDICATARIO</td><td>LOTE</td><td>IMPORTE TOTAL</td><td>TOTAL (EUROS)</td></tr>
<tr><td></td></tr>
</tbody></table>
<table><tbody><tr><td>LABORATORIOS INDAS, S.A.</td><td>12</td><td>3.814.800</td><td>22.927,41</td></tr>
<tr><td></td></tr>
<tr><td>LABORATORIOS INDAS, S.A.</td><td>14</td><td>969.600</td><td>5.827,41</td></tr>
<tr><td></td></tr>
<tr><td>JOHNSON &amp; JOHNSON, S.A.</td><td>15</td><td>194.740</td><td>1.170,41</td></tr>
<tr><td></td></tr>
<tr><td>LAB. UNITEX-HARTMANN, S.A.</td><td>16</td><td>1.120.716</td><td>6.735,64</td></tr>
<tr><td></td></tr>
<tr><td>MOLNLYCKE HEALTH CARE, S.L.</td><td>17</td><td>845.193</td><td>5.079,71</td></tr>
<tr><td></td></tr>
<tr><td>IMPORTES TOTAIS</td><td></td><td>14.836.016</td><td>89.166,25</td></tr>
<tr><td></td></tr></tbody></table>
<p>* CP 15/2000:</p>
<table><tbody><tr><td></td></tr>
<tr><td></td></tr>
<tr><td>ADXUDICATARIO</td><td>LOTE</td><td>IMPORTE TOTAL</td><td>TOTAL (EUROS)</td></tr>
<tr><td></td></tr>
</tbody></table>
<table><tbody><tr><td>BECTON DICKINSON, S.A.</td><td>1</td><td>547.500</td><td>3.290,54</td></tr>
<tr><td></td></tr>
<tr><td>BAXTER, S.L.</td><td>3</td><td>540.000</td><td>3.245,47</td></tr>
<tr><td></td></tr>
<tr><td>BAXTER, S.L.</td><td>4</td><td>342.000</td><td>2.055,46</td></tr>
<tr><td></td></tr>
<tr><td>BAXTER, S.L.</td><td>5</td><td>198.000</td><td>1.190,00</td></tr>
<tr><td></td></tr>
<tr><td>HORTAS SUMINISTROS, S.L.</td><td>6</td><td>528.580</td><td>3.176,83</td></tr>
<tr><td></td></tr>
<tr><td>B. BRAUN MEDICAL, S.A.</td><td>7</td><td>1.422.800</td><td>8.551,20</td></tr>
<tr><td></td></tr>
<tr><td>HORTAS SUMINISTROS, S.L.</td><td>8</td><td>263.476</td><td>1.583,52</td></tr>
<tr><td></td></tr>
<tr><td>BECTON DICKINSON, S.A.</td><td>9</td><td>382.100</td><td>2.296,47</td></tr>
<tr><td></td></tr>
<tr><td>BECTON DICKINSON, S.A.</td><td>10</td><td>300.000</td><td>1.803,04</td></tr>
<tr><td></td></tr>
<tr><td>BECTON DICKINSON, S.A.</td><td>11</td><td>8.207.000</td><td>49.325,06</td></tr>
<tr><td></td></tr>
<tr><td>INTERSURGICAL ESPAÑA, S.A.</td><td>12</td><td>336.900</td><td>2.024,81</td></tr>
<tr><td></td></tr>
<tr><td>CARDIVA, S.L.</td><td>14</td><td>621.900</td><td>3.737,69</td></tr>
<tr><td></td></tr>
<tr><td>ARROW IBERIA, S.A.</td><td>15</td><td>998.000</td><td>5.998,10</td></tr>
<tr><td></td></tr>
<tr><td>TÉCNICAS MÉDICAS MAB, S.A.</td><td>16</td><td>1.332.000</td><td>8.005,48</td></tr>
<tr><td></td></tr>
<tr><td>B. BRAUN DEXON, S.A.</td><td>17</td><td>453.700</td><td>2.726,79</td></tr>
<tr><td></td></tr>
<tr><td>BECTON DICKINSON, S.A.</td><td>18</td><td>3.980.000</td><td>23.920,28</td></tr>
<tr><td></td></tr>
<tr><td>KERBAK, S.A.</td><td>19</td><td>1.476.000</td><td>8.870,94</td></tr>
<tr><td></td></tr>
<tr><td>MOVACO, S.A.</td><td>20</td><td>428.750</td><td>2.576,84</td></tr>
<tr><td></td></tr>
<tr><td>IMPORTES TOTAIS</td><td></td><td>22.358.706</td><td>134.378,52</td></tr>
<tr><td></td></tr></tbody></table>
<p>* CP 16/2000:</p>
<table><tbody><tr><td></td></tr>
<tr><td></td></tr>
<tr><td>ADXUDICATARIO</td><td>LOTE</td><td>IMPORTE TOTAL</td><td>TOTAL (EUROS)</td></tr>
<tr><td></td></tr>
</tbody></table>
<table><tbody><tr><td>IBERHOSPITEX, S.A.</td><td>1</td><td>1.097.250</td><td>6.594,61</td></tr>
<tr><td></td></tr>
<tr><td>BAXTER, S.L.</td><td>2</td><td>225.700</td><td>1.356,48</td></tr>
<tr><td></td></tr>
<tr><td>MALLINCKRODT MEDICAL, S.A.</td><td>3</td><td>675.000</td><td>4.056,83</td></tr>
<tr><td></td></tr>
<tr><td>BOSS MEDICAL, S.L.</td><td>4</td><td>463.024</td><td>2.782,83</td></tr>
<tr><td></td></tr>
<tr><td>MALLINCKRODT MEDICAL, S.A.</td><td>5</td><td>294.000</td><td>1.766,98</td></tr>
<tr><td></td></tr>
<tr><td>DATEX - OHMEDA, S.L.</td><td>6</td><td>442.000</td><td>2.656,47</td></tr>
<tr><td></td></tr>
<tr><td>MALLINCKRODT MEDICAL, S.A.</td><td>7</td><td>56.250</td><td>338,07</td></tr>
<tr><td></td></tr>
<tr><td>DISTRIBUCIONES MÉDICAS, S.A.</td><td>9</td><td>171.751</td><td>1.032,24</td></tr>
<tr><td></td></tr>
<tr><td>IZASA, S..A.</td><td>10</td><td>357.000</td><td>2.145,61</td></tr>
<tr><td></td></tr>
<tr><td>DISTRIBUCIONES MÉDICAS, S.A.</td><td>11</td><td>159.750</td><td>960,12</td></tr>
<tr><td></td></tr>
<tr><td>TYCO HEALTHCARE SPAIN, S.L.</td><td>12</td><td>240.000</td><td>1.442,43</td></tr>
<tr><td></td></tr>
<tr><td>PRIM, S.A.</td><td>13</td><td>1.275.000</td><td>7.662,90</td></tr>
<tr><td></td></tr>
<tr><td>PRIM, S.A.</td><td>14</td><td>725.600</td><td>4.360,94</td></tr>
<tr><td></td></tr>
<tr><td>PRIM, S.A.</td><td>15</td><td>225.440</td><td>1.354,92</td></tr>
<tr><td></td></tr>
<tr><td>GSA GALLEGA, S.A.</td><td>16</td><td>1.248.410</td><td>7.503,10</td></tr>
<tr><td></td></tr>
<tr><td>IZASA, S..A.</td><td>17</td><td>184.500</td><td>1.108,87</td></tr>
<tr><td></td></tr>
<tr><td>DISTRIBUCIONES MÉDICAS, S.A.</td><td>18</td><td>532.755</td><td>3.201,92</td></tr>
<tr><td></td></tr>
<tr><td>IZASA, S.A.</td><td>19</td><td>97.600</td><td>586,59</td></tr>
<tr><td></td></tr>
<tr><td>B. BRAUN MEDICAL, S.A.</td><td>20</td><td>233.600</td><td>1.403,96</td></tr>
<tr><td></td></tr>
<tr><td>MALLINCKRODT MEDICAL, S.A.</td><td>21</td><td>594.500</td><td>3.573,02</td></tr>
<tr><td></td></tr>
<tr><td>TÉCNICAS MÉDICAS MAB, S.A.</td><td>22</td><td>742.500</td><td>4.462,52</td></tr>
<tr><td></td></tr>
<tr><td>MALLINCKRODT MEDICAL, S.A.</td><td>23</td><td>18.000</td><td>108,18</td></tr>
<tr><td></td></tr>
<tr><td>AMEBIL, S.A.</td><td>24</td><td>104.400</td><td>627,46</td></tr>
<tr><td></td></tr>
<tr><td>BOSS MEDICAL, S.L.</td><td>25</td><td>1.227.600</td><td>7.378,02</td></tr>
<tr><td></td></tr>
<tr><td>INTERSURGICAL ESPAÑA, S.A.</td><td>26</td><td>15.984</td><td>96,07</td></tr>
<tr><td></td></tr>
<tr><td>IMPORTE TOTAL</td><td></td><td>11.407.614</td><td>68.561,14</td></tr>
<tr><td></td></tr></tbody></table>
<p>* CP 18/2000:</p>
<table><tbody><tr><td></td></tr>
<tr><td></td></tr>
<tr><td>ADXUDICATARIO</td><td>LOTE</td><td>IMPORTE TOTAL</td><td>TOTAL (EUROS)</td></tr>
<tr><td></td></tr>
</tbody></table>
<table><tbody><tr><td>JOHNSON &amp; JOHNSON, S.A.</td><td>1</td><td>2.503.473</td><td>15.046,17</td></tr>
<tr><td></td></tr>
<tr><td>JOHNSON &amp; JOHNSON, S.A.</td><td>2</td><td>1.274.049</td><td>7.657,19</td></tr>
<tr><td></td></tr>
<tr><td>CONVATEC, S.A.</td><td>3</td><td>79.800</td><td>479,61</td></tr>
<tr><td></td></tr>
<tr><td>CONVATEC, S.A.</td><td>4</td><td>130.200</td><td>782,52</td></tr>
<tr><td></td></tr></tbody></table>
<table><tbody><tr><td></td></tr>
<tr><td></td></tr>
<tr><td>ADXUDICATARIO</td><td>LOTE</td><td>IMPORTE TOTAL</td><td>TOTAL (EUROS)</td></tr>
<tr><td></td></tr>
</tbody></table>
<table><tbody><tr><td>TYCO HEALTHCARE SPAIN, S.L.</td><td>5</td><td>96.408</td><td>579,42</td></tr>
<tr><td></td></tr>
<tr><td>JOHNSON &amp; JOHNSON, S.A.</td><td>6</td><td>389.983</td><td>2.343,84</td></tr>
<tr><td></td></tr>
<tr><td>JOHNSON &amp; JOHNSON, S.A.</td><td>7</td><td>539.999</td><td>3.245,46</td></tr>
<tr><td></td></tr>
<tr><td>JOHNSON &amp; JOHNSON, S.A.</td><td>9</td><td>305.194</td><td>1.834,25</td></tr>
<tr><td></td></tr>
<tr><td>JOHNSON &amp; JOHNSON, S.A.</td><td>10</td><td>781.725</td><td>4.698,26</td></tr>
<tr><td></td></tr>
<tr><td>JOHNSON &amp; JOHNSON, S.A.</td><td>11</td><td>3.284.369</td><td>19.739,45</td></tr>
<tr><td></td></tr>
<tr><td>JOHNSON &amp; JOHNSON, S.A.</td><td>12</td><td>500.760</td><td>3.009,63</td></tr>
<tr><td></td></tr>
<tr><td>JOHNSON &amp; JOHNSON, S.A.</td><td>13</td><td>62.569</td><td>376,05</td></tr>
<tr><td></td></tr>
<tr><td>JOHNSON &amp; JOHNSON, S.A.</td><td>14</td><td>50.333</td><td>302,51</td></tr>
<tr><td></td></tr>
<tr><td>JOHNSON &amp; JOHNSON, S.A.</td><td>15</td><td>330.219</td><td>1.984,66</td></tr>
<tr><td></td></tr>
<tr><td>JOHNSON &amp; JOHNSON, S.A.</td><td>16</td><td>85.514</td><td>513,95</td></tr>
<tr><td></td></tr>
<tr><td>JOHNSON &amp; JOHNSON, S.A.</td><td>17</td><td>9.116</td><td>54,79</td></tr>
<tr><td></td></tr>
<tr><td>JOHNSON &amp; JOHNSON, S.A.</td><td>18</td><td>713.904</td><td>4.290,65</td></tr>
<tr><td></td></tr>
<tr><td>IMPORTE TOTAL</td><td></td><td>11.137.615</td><td>66.938,41</td></tr>
<tr><td></td></tr></tbody></table>
<p>* CP 19/2000:</p>
<table><tbody><tr><td></td></tr>
<tr><td></td></tr>
<tr><td>ADXUDICATARIO</td><td>LOTE</td><td>IMPORTE TOTAL</td><td>TOTAL (EUROS)</td></tr>
<tr><td></td></tr>
</tbody></table>
<table><tbody><tr><td>B. BRAUN MEDICAL, S.A.</td><td>1</td><td>1.588.500</td><td>9.547,08</td></tr>
<tr><td></td></tr>
<tr><td>M.R.M. COMERCIAL, S.A.</td><td>2</td><td>858.000</td><td>5.156,68</td></tr>
<tr><td></td></tr>
<tr><td>CARDIVA, S.L.</td><td>3</td><td>3.520.300</td><td>21.157,43</td></tr>
<tr><td></td></tr>
<tr><td>CARDIVA, S.L.</td><td>4</td><td>91.128</td><td>547,69</td></tr>
<tr><td></td></tr>
<tr><td>CARDIVA, S.L.</td><td>5</td><td>4.590.300</td><td>27.588,26</td></tr>
<tr><td></td></tr>
<tr><td>CARDIVA, S.L.</td><td>6</td><td>1.486.000</td><td>8.931,04</td></tr>
<tr><td></td></tr>
<tr><td>IMPORTE TOTAL</td><td></td><td>12.134.228</td><td>72.928,18</td></tr>
<tr><td></td></tr></tbody></table>
<p>* CP 21/2000:</p>
<p>Cardiva, S.L.</p>
<p>Importe máximo adxudicado: 16.661.539 ptas.</p>
<p>(100.137,87 euros).</p>
<p>Prezos unitarios:</p>
<p>-Lote 1: 1.298.421 ptas. (7.803,67 euros).</p>
<p>-Lote 2: 2.239.803 ptas. (13.461,49 euros).</p>
<p>-Lote 3: 1.349.431 ptas. (8.110,24 euros).</p>
<p>Ferrol, 16 de agosto de 2000.</p>
<p>Pedro Molina Coll</p>
<p>Director xerente do Complexo Hospitalario</p>
<p>Arquitecto Marcide-Profesor Novoa Santos</p>
<p>de Ferrol</p>

